← SynDRA
TAS-103
SynDRA canonical compound SYN0045384 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | TOP1 |
|---|
| Mechanism of action | Topoisomerase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- TAS-103 free base
- J812.866I
- YVC96489QV
- RefChem:199037
- TAS-103 dihydrochloride
- UNII-YVC96489QV
- A1IUV
- SCHEMBL30479
- orb1693527
- SCHEMBL29372771
- ROWSTIYZUWEOMM-UHFFFAOYSA-N
- ZGA63408
- BDBM50610582
- AKOS030526658
- CS-3273
- TAS-103(BMS247615)
- AC-35479
- HY-13758
- T36695
- BRD-K09426783-300-01-0
- tas-103 free base
- 1X260YUP2P
- RefChem:187469
- BMS 247615
- DTXCID301510114
- GLXC-05154
- F865765
- TAS-103 HCl salt (BMS-247615)
- orb1299933
- HY-13758A
- SCHEMBL29914031
- T7309
- SCHEMBL1333536
- TAS-103 2HCl?
- EX-A455
- TAS-103 (dihydrochloride)
- CS-3272
- TAS 103 2HCl
Look up TAS-103 in the interactive SynDRA portal →